YouTube Streaming Content Graphic

YouTube Loosens Restrictions, Expands Monetization for Drug Content

Online video mainstay YouTube announced recently that it will be altering its monetization policies for three video types: educational, controversial, and content containing adult themes.

“Based on creator and advertiser input, we’ve updated our guidelines to allow more content to become eligible for full monetization (green icon) while continuing to maintain advertiser industry standards,” said YouTube in a post on its support site.

YouTube also expanded its monetization policies to allow for adult language and moderate profanity used in the first 30 seconds of a video. It includes using words like “shit” and “bitch”.

In addition, YouTube will allow ads to run on more types of content, meaning that educational, documentary, or news content can now include drug-related topics. 

“We’re expanding monetization on educational, documentary or news content that may include violent interactions with law enforcement, recreational drugs and drug-related content, or sensitive events. We’re also expanding monetization for controversial issues where non-graphic, objective discussions of controversial issues are in the video,” said YouTube in a post on its support site.

The update means more drug-related videos will now be eligible for advertising placements, including materials devoted to the discussion of drugs without promoting or “glorifying” their use, informational videos about the drug business and music videos with “fleeting depiction of drugs.”

See Also
Maine Psilocybin Bill Image

However, YouTube’s policy on the demonstration of drug use (including consumption and effects), production, and distribution, such as “how to find a dealer” or “best places to get high,” remains unaltered. 

The changes in YouTube’s policy may reflect the increasing acceptance of both cannabis and psychedelic drugs in the United States and Canada, as well as both the demand and emerging market for accessible educational content surrounding the growing sector.

What makes peyote unique among psychedelics?

Lophos Pharma is a #peyote focused psychedelics company co-founded by wife and husband duo Claire and Evan Stawnyczy to explore mescaline’s therapeutic potential.

Read the full interview here: http://ow.ly/kN6w50I3vzt

The push for medical #DMT is on. Truffle Report looks at top corporate and scientific developments involving the spirit molecule from @mindmedco, @AlgernonPharma, @entheonbiomed, @SmallPharma and more.

Full article here: http://ow.ly/khee50HXOHz

#science #business #medicine

Our CEO and Co-Founder @flobrand spoke to @amanda_siebert @Forbes to give deeper context on the significance of our donation to @MAPS and the importance of collaboration between for-profit and non-profits in tackling the #mentalhealth crisis.

See: https://www.forbes.com/sites/amandasiebert/2022/02/16/exclusive-maps-accepts-500k-donation-from-atai-life-sciences-philanthropy-arm/

A Hawaii legislative committee has approved a bill that proposes the establishment of a working group to study the therapeutic benefits of #psilocybin by a vote of 5-0.

Read the full story here: http://ow.ly/4WWI50HWJtL

#psychedelics #healing #medicine #hawaii #legal

"Inspired by a device created by in the 1950s, the creators hope to bring free transcendental experiences to 100,000 Britons – and unite the country through communal hallucinations"

https://www.theguardian.com/artanddesign/2022/feb/16/dreamachine-unboxed-brion-gysin-jon-hopkins-assemble

Load More...

Related Articles

Scroll To Top